Comparison of in situ excision and whole-globe recovery of corneal tissue in a large, single eye bank series

Am J Ophthalmol. 2010 Sep;150(3):427-433.e1. doi: 10.1016/j.ajo.2010.03.021. Epub 2010 Jun 8.

Abstract

Purpose: To compare the quality of corneal tissue after 2 different procurement techniques, whole-globe enucleation and in situ excision.

Design: Cross-sectional study.

Methods: Data in the interval 2005 to 2008 were collected from the Lions Eye Bank of Oregon. A total of 3618 eyes underwent whole-globe enucleation (enucleation group) and 2048 eyes were subject to in situ excision (in situ group). Endothelial cell density (ECD) and death-to-preservation time (D-to-P) were analyzed. Grading scores ranging from 0 (excellent) to 4 (unacceptable for transplantation) were used to evaluate the epithelium, stroma, Descemet fold, and overall endothelium. The incidences of ECD less than 2000 cells/mm(2) (ECD <2000), primary graft failure (PGF), and postoperative infection were investigated.

Results: ECD was 2726 +/- 419 cells/mm(2) in the enucleation and 2645 +/- 395 cells/mm(2) in the in situ group (P < .001). D-to-P was 9.81 +/- 3.56 hours and 8.90 +/- 3.65 hours, respectively (P < .001). The mean grade of the stroma was 1.44 +/- 0.51 in the enucleation group and 1.50 +/- 0.56 in the in situ group (P = .001). The mean grades of overall endothelium were 1.51 +/- 0.72 and 1.58 +/- 0.69, respectively (P < .001). The incidence of ECD <2000 was 2.38% in the enucleation group and 2.39% in the in situ group (P > .999), PGF rates were 0.72% and 0.68% (P > .999), and postoperative infection levels were 0.14% and 0.39% (P = .080).

Conclusion: Although there were minor differences in parameters related to the endothelium, in situ excision seemed equivalent to whole-globe enucleation when various parameters were evaluated.

Publication types

  • Comparative Study

MeSH terms

  • Cell Count
  • Chondroitin Sulfates
  • Complex Mixtures
  • Cornea*
  • Corneal Transplantation
  • Cross-Sectional Studies
  • Cryopreservation*
  • Dextrans
  • Endothelium, Corneal / pathology
  • Eye Banks / methods*
  • Eye Enucleation*
  • Gentamicins
  • Graft Survival
  • Humans
  • Middle Aged
  • Organ Preservation Solutions
  • Organ Preservation*
  • Tissue Donors*
  • Tissue and Organ Harvesting / methods*
  • Tissue and Organ Procurement

Substances

  • Complex Mixtures
  • Dextrans
  • Gentamicins
  • Organ Preservation Solutions
  • Chondroitin Sulfates
  • Optisol